1. Mullins CE, O'Laughlin MP, Vick GW 3rd, et al. Implantation of balloon-expandable intravascular grafts by catheterization in pulmonary arteries and systemic veins. Circulation. 1988. 77:188–199.
2. Hellenbrand WE. Transcatheter therapy for congenital heart disease. Cardiol Clin. 1988. 6:421–436.
3. Rath PC, Sukumar IP. Transcatheter therapy for congenital heart disease. J Assoc Physicians India. 1986. 34:199–201.
4. Chaturvedi RR, Kilner PJ, White PA, Bishop A, Szwarc R, Redington AN. Increased airway pressure and simulated branch pulmonary artery stenosis increase pulmonary regurgitation after repair of tetralogy of Fallot. Real-time analysis with a conductance catheter technique. Circulation. 1997. 95:643–649.
5. Fogelman R, Nykanen D, Smallhorn JF, McCrindle BW, Freedom RM, Benson LN. Endovascular stents in the pulmonary circulation: clinical impact on management and medium-term follow-up. Circulation. 1995. 92:881–885.
6. Oyen WJ, van Oort AM, Tanke RB, van Mill GJ, Aengevaeren WR, Corstens FH. Pulmonary perfusion after endovascular stenting of pulmonary artery stenosis. J Nucl Med. 1995. 36:2006–2008.
7. Latson LA. Interventional catheterization for congenital heart disease--limited "surgery" without the chest scar. Clin Pediatr (Phila). 1997. 36:125–127.
8. Petit CJ, Gillespie MJ, Harris MA, et al. Relief of branch pulmonary artery stenosis reduces pulmonary valve insufficiency in a swine model. J Thorac Cardiovasc Surg. 2009. 138:382–389.
9. Law MA, Shamszad P, Nugent AW, et al. Pulmonary artery stents: long-term follow-up. Catheter Cardiovasc Interv. 2010. 75:757–764.
10. Recto MR, Elbl F, Austin E. Use of the new IntraStent for treatment of transverse arch hypoplasia/coarctation of the aorta. Catheter Cardiovasc Interv. 2001. 53:499–503.
11. Rutledge JM, Mullins CE, Nihill MR, Grifka RG, Vincent JA. Initial experience with intratherapeutics Intrastent Doublestrut LD stents in patients with congenital heart defects. Catheter Cardiovasc Interv. 2002. 56:541–548.
12. Latson LA. Pulmonary artery stents: on target, but still "off label". Catheter Cardiovasc Interv. 2010. 75:765–766.
13. Moszura T, Michalak KW, Dryzek P, Moll JA, Moll J, Sysa A. One center experience in pulmonary artery stenting without long vascular sheath. Cardiol J. 2010. 17:149–156.
14. Tomita H, Nakanishi T, Hamaoka K, Kobayashi T, Ono Y. Stenting in congenital heart disease: medium- and long-term outcomes from the JPIC stent survey. Circ J. 2010. 74:1676–1683.
15. Forbes TJ, Rodriguez-Cruz E, Amin Z, et al. The Genesis stent: a new low-profile stent for use in infants, children, and adults with congenital heart disease. Catheter Cardiovasc Interv. 2003. 59:406–414.
16. Breinholt JP, Nugent AW, Law MA, Justino H, Mullins CE, Ing FF. Stent fractures in congenital heart disease. Catheter Cardiovasc Interv. 2008. 72:977–982.
17. Ashwath R, Gruenstein D, Siwik E. Percutaneous stent placement in children weighing less than 10 kilograms. Pediatr Cardiol. 2008. 29:562–567.
18. Li F, Zhou AQ, Gao W, et al. Therapeutic effect of Cheatham-Platinum stent implantation for vessel stenosis associated with congenital heart disease in children and adolescents. Zhonghua Er Ke Za Zhi. 2009. 47:255–259.
19. Maglione J, Bergersen L, Lock JE, McElhinney DB. Ultra-high-pressure balloon angioplasty for treatment of resistant stenoses within or adjacent to previously implanted pulmonary arterial stents. Circ Cardiovasc Interv. 2009. 2:52–58.